| Literature DB >> 32734080 |
Jean Bienvenue Ouoba1,2, Kuan Abdoulaye Traore1,3, Hortense Rouamba1,4, Komi Victor-Mari Setondji1, Germaine L Minoungou5, Bruno Lalidia Ouoba5, Anne Ouedraogo5, Sidi Moctar5, Alphonsine Kouassi M'Bengue2, Solange Ngazoa Kakou2, Moussa Doumbia2, Alfred S Traore1, Pierre Roques6,7,8, Nicolas Barro1.
Abstract
Four major genotypes of Hepatitis E virus (HEV) have been documented worldwide (1-4) with genotypes 1 and 2 found in human in Sub-Saharan Africa. Human Hepatitis cases due to HEV genotype 3 and 4 are zoonotic with various animal identified as possible reservoirs. Recently, HEV genotype 3 was found in pigs and human beings in West Africa, which may change the epidemic in human. Here, we assessed the prevalence of HEV antibodies in various domestic and wild mammalians in Burkina Faso. Random sampling was performed between 2015 and 2017 to collect serum from 100 rabbits (Oryctolagus cuniculus), 19 hares (Lepus africana), 72 cattle (Bos taurus), 75 sheep (Ovis aries) and 81 goats (Capra aegagrus) in three provinces in Burkina Faso. A multi-species ELISA was performed on serum samples from 328 domestic animals and 19 hunting hares. HEV total antibodies were identified in 121 out of 347 specimens (34.9% CI95% [29.9-39.9]). Sera from rabbits (60% CI95% [50.4-69.6]), hares (52.6% CI95% [30.2-75.1]), cattle (26.4% CI95% [16.2-36.6]), sheep (12.0% CI95% [4.6-19.4]), and goats (28.4% CI95% [18.6-38.2]) tested positive for antibodies anti-HEV. In this study we evidence presence of HEV antibodies in various mammalians and highlight the importance of these species in the epidemiology of HEV infection in Burkina Faso.Entities:
Keywords: Burkina Faso; Hepatitis E virus; Lagomorphs; Seroprevalence; Ungulata; Zoonosis
Year: 2019 PMID: 32734080 PMCID: PMC7386747 DOI: 10.1016/j.vas.2019.100059
Source DB: PubMed Journal: Vet Anim Sci ISSN: 2451-943X
Fig. 1Map of sampling sites
Note: The map shows sampling sites (surrounded in green) that correspond to areas of high human population density and hunting areas. It presents three study regions stretching from East to West. The high human density is increasing from yellow to red. The density of the population varies from 3 to 22 inhabitants per hectare.
Comparison of seroprevalence rates per animal species between seroprevalences recorded in different countries and the results of our study.
| Prevalence from literature | Seroprevalence in our study | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Species /Expected genotype | Method ELISA | Method PCR | ||||||||
| Percent | Positive / Total | Method ELISA Used | Percent (%) | Positive / Total | Ref* | Countries / Year of study | Percent | Positive/Total | IC 95% | |
| Rabbit Gen: 3 | 54.6 | 65/119 | Commercial kit (Wantai) | 6.9 | 8/115 | China (North) / 2010 | 60.0 | 60/100 | [50.4–69.6] | |
| 37.3 | 47/126 | Commercial kit (Wantai) | 17.1 | 28/164 | Germany / 2016 | |||||
| 36.0 | 31/85 | In-house test | 16.0 | 14/85 | USA (Virginia) / 2011 | |||||
| 57.0 | 191/335 | Commercial kit (Wantai) | 7.6 | 11/144 | China (North) / 2009 | |||||
| 15.4 | 169/1094 | Commercial kit (Wantai) | 2.0 | 22/1094 | China (North; Northeast; North; South East; South) / 2010 | |||||
| 3.4 | 7/206 | In-house test | 0.0 | 0/206 | Italy / 2015 | |||||
| 72.5 and 62.5 | 58/80 and 50/80 | Commercial kit (Wantai) for human and In-house test for swine sera | 46.1 | 24/52 | China (Center) / 2017 | |||||
| Hare | 2.2 | 14/624 | Commercial kit (Axiom corresponding to the assay produced by Wantai,) | 0.0 | 0/624 | Germany / 2016 | 52.6 | 10/19 | [30.2–75.1] | |
| 0.0 | Commercial kit (DIA.PRO) | – | – | Italy / 2015 | ||||||
| Cattle Gen: 4d | 15.0 | 52/346 | Commercial kit (Wantai) | – | – | China (North) / 2010 | 26.4 | 19/72 | [16.2–36.6] | |
| 28.2 | 257/912 | Commercial kit (Wantai) | 0.8 | 7/912 | China / 2008 (center, North, South, East and West) | |||||
| 6.0 | 6/100 | Commercial kit (Wantai) | 0.0 | 0/100 | China (East) / 2004-2006 | |||||
| 15.0 | 174/1156 | In-house test | – | – | USA (Virginia) / 2011 | |||||
| Sheep Gen: 4d | 100.0 And 77.5% | 58/58 And 45/58 | Genelabs Diagnostics (Commercial kit) and In-house test | 0.0 | 0/58 | India / 2006 | 12.0 | 9/75 | [4.6–19.3] | |
| 10.5 | 2/19 | Diagnostic Automation (commercial kit for human) | – | – | Nigeria / 2012 | |||||
| 31.8 | 56/176 | ID-vet (commercial kit) | – | – | Nigeria / 2016 | |||||
| 35.2 | 176/500 | Commercial kit (Wantai) | 5.3 | 4/75 | China (West) / 2014 | |||||
| Goat Gen: 3c | 100.0 | 86/86 | Genelabs Diagnostics (Commercial kit) and In-house test | 0.0 | 0/86 | India / 2006 | 28.4 | 23/81 | [18.6–38.2] | |
| 10.4 | 73/700 | Commercial kit (Wantai) | 1.6 | 11/700 | China (center, North, South, East and West) / 2008 | |||||
| 37.2 | 16/43 | Diagnostic Automation (commercial kit for human | – | – | Nigeria / 2012 | |||||
| 16.0 | 13/80 | In-house test | 0.0 | 0/80 | USA (Virginia) / 2002 | |||||
| 24.0 | 12/50 | Commercial kit (Wantai) | 0.0 | 0/50 | China (East) / 2004-2006 | |||||
| 0.0 | 0/5 | In-house test | – | – | Brasil / 2005 | |||||
Note: * references.
Comparison of prevalence of total antibodies anti-hepatitis E 477 virus in the different animal species and the three provinces of Burkina Faso.
| Species | Seroprevalence (%) and 95% CI | Seroprevalence (%) in provinces and 95% CI | ||
|---|---|---|---|---|
| Kadiogo | Houet | Gourma | ||
| 60.0 [50.4–69.6] | 80.4 [70.0–90.8] | 19.2 [4.1–34.4] | 55.6 [32.6–78.5] | |
| 52.6 [30.2–75.1] | NS | 66.67 [13.3–100.0] | 50.00 [25.5–74.5] | |
| 26.4 [16.2–36.6] | 26.4 [16.2–36.6] | NS | NS | |
| 12.0 [4.6–19.4] | 12.0 [4.6–19.4] | NS | NS | |
| 28.4 [18.6–38.2] | 28.4 [18.6–38.2] | NS | NS | |
Note: CI = confidence interval. NS = No Sample.
Fig. 2Distribution of the positive and negative cases according to the Optical Density
Note: Distribution of the positive and negative cases according to the Optical Density (OD) of samples from the various species studied. Positive cases are in red and negative cases are in black. Positive samples were defined according to the Kit CUT-OFF value according to the internal standard of each assay.
Comparison of prevalence of total antibodies Anti-HEV in domestic and wilds animals in three developed provinces and two rural provinces of Burkina Faso according to different animal species, genders and localities.
| Nr positive/nr tested | Total antibodies anti-HEV% | Odds ratio | IC95% Odds ratio | |||
|---|---|---|---|---|---|---|
| Rabbits | 60 (/100) | 60.0 ± 9.6 | Ref | Ref | Ref | Ref |
| Cattle | 19 (/72) | 26,4 ± 10.2 | 1.3.10−8 | 11,6 | [5.2–28.2] | <0.001⁎⁎⁎ |
| Goats | 23 (/81) | 28.4 ± 9.8 | 1.9.10−8 | 10.5 | [4.8–24.9] | <0.001⁎⁎⁎ |
| Hares | 10 (/19) | 52.6 ± 22.5 | 0.6 | 0.8 | [0.2–2.6] | >0.05 |
| Sheep | 9 (/75) | 12.0 ± 7.4 | 3.2.10−12 | 31.3 | [12.5–87.5] | <0.001⁎⁎⁎ |
| Female | 61 (/180) | 33.9 ± 6.9 | Ref | Ref | Ref | Ref |
| Males | 60 (/167) | 35.9 ± 7.3 | 0.5 | 0.8 | [0.5–1.4] | >0.05 |
| Houet | 7 (/29) | 24.1 ± 15.6 | Ref | Ref | Ref | Ref |
| Gourma | 18 (/34) | 52.9 ± 16.8 | 0.04 | 3.3 | [1.0–11.2] | <0.05* |
| Kadiogo | 96 (/284) | 33.8 ± 5.5 | 2.4.10−6 | 13.9 | [4.9–44.4] | <0.001⁎⁎⁎ |
Note: OR, odds ratio; CI, confidence interval; *, statistically significant. Statistically significant analyzes in the study were shown in the figure with an asterisk (*); *, statistically significant and P value ˂ 0.05.